WHEN:
|
Tuesday, July 28,
2020
|
|
2 p.m. – 5:30 p.m.
GMT | 10 a.m. – 1:30 p.m.
EDT | Virtual video
event
|
|
To submit questions
for panelists, please contact:
|
|
•
|
Roger Frizzell
|
rfrizzell@carnival.com | (305) 406-7862
|
|
•
|
Ellie Beuerman
| ellie@ldwwgroup.com | (504) 994-9673
|
|
•
|
World Travel &
Tourism Council (WTTC) Press Office |
press.office@wttc.org
|
|
|
|
|
|
WHERE:
|
To register for the
event, click here: https://covidsciencesummit.com/
|
|
You will receive an
email with a webcast link prior to the start of the
event.
|
|
|
|
|
|
WHAT:
|
The
WTTC/Carnival Corporation Global Scientific Summit on
COVID-19 is being presented to help the general public,
businesses and civic/community leaders continue building an
understanding of the facts about COVID-19.
|
|
|
|
|
|
|
The event will
include a series of panels focusing on critical areas of science
related to COVID-19. During a combination of accessible
science-based discussions sharing the latest knowledge of key topic
areas, speakers will examine real-time insights and the most
up-to-date scientific findings from across all fields of knowledge
in the public and private sectors, including:
|
|
|
|
|
|
|
•
|
Epidemiology: Incubation and peak
infectivity periods for COVID-19; disease progression from exposure
to illness; and symptom variability.
|
|
•
|
Transmission: How, when and where
COVID-19 spreads; significance of environmental transmission;
guidelines for mitigating spread.
|
|
•
|
Screening and
Testing: Availability and accuracy of current testing
methods; viable and cost-effective ways to detect illness and
effectiveness of various screening methods.
|
|
•
|
Therapeutics: Status of vaccine
development; available and approved COVID-19 treatment protocols
and profiles of COVID-19 recovery.
|
|
•
|
Practical Risk
Mitigation: The best approaches to mitigating spread; the
key elements of protocols and behaviors needed to live in a world
with the virus.
|
|
|
|
|
|
|
The event is designed
for the general public and free to attend; registration is now
open.
|
|
|
|
|
|
WHO:
|
The virtual Summit is
hosted by World Travel & Tourism Council (WTTC), which
represents the global travel and tourism private sector, and
Carnival Corporation, the world's largest cruise company. Event
moderators include:
|
|
|
|
|
|
|
•
|
Arnold Donald,
president & CEO, Carnival Corporation
|
|
•
|
Gloria
Guevara, president & CEO, WTTC
|
|
|
|
|
|
|
Donald and Guevara
will encourage straightforward, easy-to-understand discussions
among a group of top medical, epidemiology and public health
experts, including the following two health leaders just
recently added from St. Jude Children's Research Hospital (in
alphabetical order):
|
|
|
|
|
|
|
•
|
Dr. Stacey L.
Schultz-Cherry, PhD, faculty member, St. Jude Children's
Research Hospital and co-principal investigator, St Jude Center for
Excellence in Influenza Research and Surveillance. An expert in
virus pathogenesis novel vaccines and therapeutics and microbial
co-infection, she is also deputy director, World Health
Organization Collaborating Centre for Studies on the Ecology of
Influenza in Animals & Birds.
|
|
|
|
|
|
|
•
|
Dr. Joshua Wolf,
PhD, MBBS, associate faculty member and pediatric infectious
diseases physician, St. Jude Children's Research Hospital, and
medical director of antimicrobial stewardship and program lead for
hematology and oncology infectious diseases for the organization.
He is an expert in infections in immunocompromised children, with a
research program dedicated to improving survival in children with
cancer by prediction, prevention and amelioration of
life-threatening infections.
|
|
|
|
|
|
|
The St. Jude
representatives join the following lineup of world-renowned experts
representing a diverse range of science, research, clinical,
academic, policy and business backgrounds including members of
Scientists to Stop COVID-19: (in alphabetical order):
|
|
|
|
|
|
|
•
|
Dr. Thomas J.
Cahill, MD, PhD, founder and managing partner of Newpath
Management, L.P. He earned both his MD and PhD from Duke
University. His PhD work with professor Robert Lefkowitz (Nobel
laureate) focused on studying cellular receptors and their
signaling to inform novel drug development and
discovery.
|
|
•
|
Dr. Julio Frenk,
MD, MPH, PhD, president of the University of Miami,
professor of public health sciences, the Leonard M. Miller School
of Medicine, and professor of health sector management and policy,
the Patti and Allan Herbert School of Business. He served as the
Minister of Health of Mexico, helping to reform the nation's health
system by introducing comprehensive universal coverage, known as
Seguro Popular.
|
|
•
|
Dr. Adolfo
Garcia-Sastre, PhD, director, Global Health & Emerging
Pathogens Institute, The Icahn School of Medicine, Mount Sinai and
professor of microbiology and medicine, infectious disease. He has
focused on a wide variety of viral pathogens, as well as
host-pathogen interactions, and vaccine and anti-viral drug
development.
|
|
•
|
Dr. Steven Gordon,
MD, chairman, department of infectious disease, Cleveland
Clinic, Respiratory Institute and professor of medicine, The Lerner
College of Medicine, Case Western University. He has focused on
hospital infection prevention, including device-associated and
opportunistic infections in immunocompromised patients.
|
|
•
|
Dr. Michael Z.
Lin, MD, PhD, associate professor of neurobiology,
bioengineering, and chemical and systems biology at Stanford
University. A NIH Pioneer Award recipient, he develops protein
based tools for molecular imaging and control of gene and viral
therapy.
|
|
•
|
Dr. William
Morice, II, MD, PhD, chair, department of laboratory medicine
and pathology at Mayo Clinic, president, Mayo Clinic Laboratories,
and professor of laboratory medicine and pathology. He is an expert
in diagnostic testing, serving in leadership roles for numerous
boards and partnerships to enhance understanding of clinical
diagnostics and test utilization.
|
|
•
|
Dr. Jewel Mullen,
MD, MPH, associate dean for health equity, University of Texas
at Austin, Dell Medical School. She is an internist, epidemiologist
and public health physician leader and the former principal deputy
assistant secretary for health in the U.S. Department of Health and
Human Services.
|
|
•
|
Dr. Vivek Murthy,
MD, MBA, author, former vice admiral in the Public Health
Service Commissioned Corps and 19th Surgeon General of the United
States. In that role, he created initiatives to tackle the
country's most urgent public-health issues, including the Ebola and
Zika viruses, obesity, mental health, and the opioid
crisis.
|
|
•
|
Dr. Michael
Rosbash, PhD, is the 2017 Nobel laureate in physiology or
medicine, a member of the National Academy of Sciences, a professor
of biology at Brandeis University, and a Howard Hughes Medical
Institute Investigator. He is a pioneer of chronobiology, the study
of how living systems sense and respond to time.
|
|
•
|
Dr. Stuart
Schreiber, PhD, professor of chemistry and chemical
biology at Harvard University and co-founder of the Broad
Institute. He is a member of the National Academy of Sciences, and
a founder of Vertex Pharmaceuticals, Ariad Pharmaceuticals,
Infinity Pharmaceuticals, Forma Therapeutics, H3 Biomedicine and
Jnana Therapeutics. He co-pioneered the field of chemical
biology.
|
|
|
|
|
|
WHO SHOULD
ATTEND:
|
This Summit will be
of interest to the general public, as well as global tourism
leaders, including WTTC Members, government agencies, destination
partners, trade partners and private businesses seeking valuable
insight on how best to apply the latest science and
medical-evidence to address the many practical questions people
have about living in a world with COVID-19. The open discussion
will be helpful as businesses and governments alike seek to better
understand COVID-19's impact on society, and as together global
citizens join forces to consider safe and practical evidence-based
practices for mitigating and living with the virus.
|
|
|
|
|
|
MORE
INFO:
|
Media are invited to
submit potential questions for panelists in advance by
contacting:
|
|
•
|
Frizzell
| rfrizzell@carnival.com |
(305) 406-7862
|
|
•
|
Ellie Beuerman
| ellie@ldwwgroup.com
| (504) 994-9673
|
|
•
|
WTTC Press Office
| press.office@wttc.org
|